Radiation Therapy for Multiple Myeloma

Phase-Based Progress Estimates
Emory University Hospital/Winship Cancer Institute, Atlanta, GAMultiple Myeloma+2 MoreRadiation Therapy - Radiation
All Sexes
What conditions do you have?

Study Summary

This trial is testing how well low-dose radiotherapy works to treat bone pain in patients with multiple myeloma that has spread to the bone.

Eligible Conditions
  • Multiple Myeloma
  • Bone Metastasis
  • Ostealgia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Up to 6 months after completion of radiation therapy

Month 6
Pain response
Quality of life (QOL) as measured by European Organization for Research and Treatment of Cancer Metastases Module (EORTC QLQ-BM22)
Quality of life (QOL) as measured by European Organization for Research and Treatment of Cancer Quality of life Questionnaire Core 30 (EORTC QLQ-C30)

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Treatment (low-dose radiation therapy)
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: Radiation Therapy · No Placebo Group · N/A

Treatment (low-dose radiation therapy)Experimental Group · 3 Interventions: Questionnaire Administration, Radiation Therapy, Quality-of-Life Assessment · Intervention Types: Other, Radiation, Other
First Studied
Drug Approval Stage
How many patients have taken this drug
Radiation Therapy
Completed Phase 3

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 6 months after completion of radiation therapy

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,153 Previous Clinical Trials
41,162,233 Total Patients Enrolled
557 Trials studying Multiple Myeloma
192,832 Patients Enrolled for Multiple Myeloma
University of Southern CaliforniaLead Sponsor
831 Previous Clinical Trials
1,430,892 Total Patients Enrolled
3 Trials studying Multiple Myeloma
69 Patients Enrolled for Multiple Myeloma
Leslie Ballas, MDPrincipal InvestigatorUniversity of Southern California

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You report experiencing pain with a score of 2 or more on the Brief Pain Inventory.

Frequently Asked Questions

In what geographical areas is this scientific research being conducted?

"This trial is now welcoming participants at 8 distinct sites, including Boston, Los Angeles and Minneapolis. To reduce the strain of travel on yourself or your family if you decide to join this medical study, it is advised to select a site proximal to you." - Anonymous Online Contributor

Unverified Answer

Is this research endeavor currently enrolling participants?

"Affirmative. Clinicaltrials.gov documents that this clinical research is actively recruiting participants, having been initially posted on March 11th 2019 and last amended February 25th 2022. In total, 8 sites are aiming to recruit 100 individuals for the trial." - Anonymous Online Contributor

Unverified Answer

What is the present enrollment figure for this research project?

"This medical trial necessitates the enrollment of 100 qualified individuals. Patients in Boston, MA and Los Angeles, CA can access the study's resources at Dana-Farber Cancer Institute and USC / Norris Comprehensive Cancer Center respectively." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.